Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.10%
SPX
-0.03%
IXIC
+0.13%
FTSE
+0.11%
N225
0.00%
AXJO
0.00%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...
Join our newsletter to keep up to date with us!

Recently from Cashu

publisher logo
Cashu

Wojcicki's Nonprofit Bests Regeneron in 23andMe Acquisition Amid Bankruptcy Struggles

2 days ago
publisher logo
Cashu

Regeneron Pharmaceuticals: Innovative Collaboration Tackles Obesity with Deep Apple and Novo Nordisk

4 days ago
publisher logo
Cashu

Regeneron Pharmaceuticals Strengthens Leadership in Respiratory Disease Treatments Amid Competition

6 days ago

Key Stats

Market Cap
55.63B
Dividend Yield
0.00%
P/E Ratio
12.36
EPS
40.89
Revenue
14.20B
Avg. Volume
1.66M

About

What does REGN do?
Regeneron Pharmaceuticals, headquartered in Tarrytown, New York, focuses on developing medicines for serious diseases, employing 13,450 people. Its key products include EYLEA, Dupixent, and Libtayo, utilizing advanced technologies like VelociSuite.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
New York, USA
Website
http://www.regeneron.com
Stocks
Health Care
regn
Regeneron Pharmaceuticals
REGN
+4.42 (+0.87%)
513.28
USD
At close at Jun 18, 20:36 UTC
Summary
News
Signals
Benchmarks
Financials